Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis
- PMID: 18603457
- DOI: 10.1016/j.ejpain.2008.05.014
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis
Abstract
Although clinical studies show that cannabinoids improve central pain in patients with multiple sclerosis (MS) neurophysiological studies are lacking to investigate whether they also suppress these patients' electrophysiological responses to noxious stimulation. The flexion reflex (FR) in humans is a widely used technique for assessing the pain threshold and for studying spinal and supraspinal pain pathways and the neurotransmitter system involved in pain control. In a randomized, double-blind, placebo-controlled, cross-over study we investigated cannabinoid-induced changes in RIII reflex variables (threshold, latency and area) in a group of 18 patients with secondary progressive MS. To investigate whether cannabinoids act indirectly on the nociceptive reflex by modulating lower motoneuron excitability we also evaluated the H-reflex size after tibial nerve stimulation and calculated the H wave/M wave (H/M) ratio. Of the 18 patients recruited and randomized 17 completed the study. After patients used a commercial delta-9-tetrahydrocannabinol (THC) and cannabidiol mixture as an oromucosal spray the RIII reflex threshold increased and RIII reflex area decreased. The visual analogue scale score for pain also decreased, though not significantly. Conversely, the H/M ratio measured before patients received cannabinoids remained unchanged after therapy. In conclusion, the cannabinoid-induced changes in the RIII reflex threshold and area in patients with MS provide objective neurophysiological evidence that cannabinoids modulate the nociceptive system in patients with MS.
Similar articles
-
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.Neurology. 2005 Sep 27;65(6):812-9. doi: 10.1212/01.wnl.0000176753.45410.8b. Neurology. 2005. PMID: 16186518 Clinical Trial.
-
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.Clin Ther. 2007 Sep;29(9):2068-79. doi: 10.1016/j.clinthera.2007.09.013. Clin Ther. 2007. PMID: 18035205 Clinical Trial.
-
[Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication].Ugeskr Laeger. 2005 Jun 20;167(25-31):2772-4. Ugeskr Laeger. 2005. PMID: 16014264 Clinical Trial. Danish.
-
The lower limb flexion reflex in humans.Prog Neurobiol. 2005 Dec;77(6):353-95. doi: 10.1016/j.pneurobio.2005.11.003. Epub 2005 Dec 28. Prog Neurobiol. 2005. PMID: 16386347 Review.
-
[Pain relief with cannabinoids-- the importance of endocannabinoids and cannabinoids for pain therapy].Anasthesiol Intensivmed Notfallmed Schmerzther. 2008 Jul;43(7-8):522-8. doi: 10.1055/s-0028-1083094. Anasthesiol Intensivmed Notfallmed Schmerzther. 2008. PMID: 18671173 Review. German.
Cited by
-
Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System.J Clin Med. 2023 Nov 13;12(22):7071. doi: 10.3390/jcm12227071. J Clin Med. 2023. PMID: 38002684 Free PMC article. Review.
-
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials.Curr Neuropharmacol. 2023;21(12):2505-2515. doi: 10.2174/1570159X21666230727094431. Curr Neuropharmacol. 2023. PMID: 37519000 Free PMC article.
-
Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature.PLoS One. 2023 Feb 17;18(2):e0281826. doi: 10.1371/journal.pone.0281826. eCollection 2023. PLoS One. 2023. PMID: 36800328 Free PMC article. Review.
-
Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis.PLoS One. 2023 Jan 30;18(1):e0267420. doi: 10.1371/journal.pone.0267420. eCollection 2023. PLoS One. 2023. PMID: 36716312 Free PMC article.
-
Dysmenorrhoea: Can Medicinal Cannabis Bring New Hope for a Collective Group of Women Suffering in Pain, Globally?Int J Mol Sci. 2022 Dec 19;23(24):16201. doi: 10.3390/ijms232416201. Int J Mol Sci. 2022. PMID: 36555842 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical